Obexelimab Completed Phase 2 Trials for Systemic Lupus Erythematosus Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02725515 | A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus |